September 26, 2022
In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.
March 7, 2012
…Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for improving memory deficits and reducing the pathology of Alzheimer’s disease (AD) in an animal model representative of most AD patients.
June 15, 2017
University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.
October 8, 2024
As family, friends and loved ones looked on proudly, more than 70 pharmacy students were inducted into the profession at the UC San Diego Skaggs School of Pharmaceutical and Pharmaceutical Sciences White Coat ceremony.
March 17, 2014
…of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer’s disease. Moreover, the candidate inhibitor drug has been shown to be safe in humans.
November 1, 2022
New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.
May 9, 2017
Scientists at the Center for Marine Biotechnology and Biomedicine at Scripps Institution of Oceanography at the University of California San Diego have contributed to a new study, published May 1 in in the journal Proceedings of the National Academy of Sciences, that asks the question: are there any valuable products…
February 26, 2015
…School of Pharmacy and Pharmaceutical Sciences Last July, Dr. James H. McKerrow became only the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences, which opened its doors to its first class in the fall of 2002. McKerrow is also an alumnus of UC San Diego—he earned his…
June 26, 2023
Researchers with UC San Diego School of Medicine identified a potential new drug that improved liver fibrosis in patients with NASH by 27%.
September 7, 2016
One of the hundreds of companies hatched by the University of California San Diego has a prominent presence in a national showcase of high-potential startups in the nation’s capital. Curtana Pharmaceuticals plays a big role in the high-visibility Washington, D.C. celebration as a major presenter.
